<\/p>\n\n\n\n
Mary Laura Lind (Marylaura Lind Thomas) is Professor of\u00a0Chemical Engineering\u00a0in the School for Engineering of Matter,\u00a0Transport and Energy at Arizona State University. She served as the Graduate Program Chair of Chemical Engineering from 2015 – 2021. In 2021 she was appointed as a Fulton\u00a0Entrepreneurial Professor. She is also affiliated with the Biodesign Center for Bioelectronics and\u00a0Biosensors\u00a0and has a Research Affiliate appointment at the\u00a0Mayo Clinic (Arizona) in the Division of Nephrology and\u00a0Hypertension.\u00a0She is the co-founder of Sequitur Health Corporation.<\/a><\/p>\n\n\n\n Lind joined ASU in August 2010 as an Assistant Professor. Prior to ASU, Lind completed a California Nanosystems Institute Pioneer Postdoctoral Fellowship at the University of California Los Angeles in the Civil and Environmental Engineering Department. Previously Lind received her master’s degree and doctorate in materials science from the California Institute of Technology under the guidance of Professor William L. Johnson, and a bachelor’s degree in chemical engineering from Yale University.<\/p>\n\n\n\nEducation<\/h2>\n\n\n\n
\n